Evidence map›Paper›PMID 22863174›Full record

ArticleEJNMMI research2012

Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy.

Stefan Brunner, Andrei Todica, Guido Böning, Stefan G Nekolla, Moritz Wildgruber, Sebastian Lehner, Martina Sauter, Christopher Ubleis, Karin Klingel, Paul Cumming and 2 more

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Detection of apoptosis by [Annals of nuclear medicine · 2023
    Article
  4. Detection of cardiac apoptosis by [Molecular imaging and biology · 2022
    Article
  5. Article
  6. Article
  7. The Number of Frames on ECG-GatedMolecular imaging · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. In-vivo monitoring of erythropoietin treatment after myocardial infarction in mice with [⁶⁸Ga]Annexin A5 and [¹⁸F]FDG PET.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2014
    Article
  14. Article
  15. Article
  16. Positron emission tomography in the assessment of left ventricular function in healthy rats: a comparison of four imaging methods.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Stefan BrunnerDepartment of Nuclear Medicine, Ludwig-Maximilians-University, Klinikum Grosshadern, Marchioninistr 15, Munich, 81377, Germany. marcus.hacker@med.uni-muenchen.de.
Andrei Todica
Guido Böning
Stefan G Nekolla
Moritz Wildgruber
Sebastian Lehner
Martina Sauter
Christopher Ubleis
Karin Klingel
Paul Cumming
Wolfgang Michael Franz
Marcus Hacker
Ludwig-Maximilians-Universität München · DEUniversity of Tübingen · DEABX-CRO Advanced Pharmaceutical Services (Germany) · DEKlinikum rechts der Isar · DETechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe performed an initial evaluation of non-invasive ECG-gated [18 F]FDG-positron emission tomography (FDG-PET) for serial measurements of left ventricular volumes and function in murine models of dilated (DCM) and ischemic cardiomyopathy (ICM), and then tested the effect of erythropoietin (EPO) treatment on DCM mice in a preliminary FDG-PET therapy monitoring study.

methodsMice developed DCM 8 weeks after injection with Coxsackievirus B3 (CVB3), whereas ICM was induced by ligation of the left anterior descending artery. LV volumes (EDV and ESV) and the ejection fraction (LVEF) of DCM, ICM and healthy control mice were measured by FDG-PET and compared with reference standard results obtained with 1.5 T magnetic resonance imaging (MRI). In the subsequent monitoring study, LVEF of DCM mice was evaluated by FDG-PET at baseline, and after 4 weeks of treatment, with EPO or saline.

resultsLV volumes and the LVEF as measured by FDG-PET correlated significantly with the MRI results. These correlations were higher in healthy and DCM mice than in ICM mice, in which LVEF measurements were somewhat compromised by absence of FDG uptake in the area of infarction. LV volumes (EDV and ESV) were systematically underestimated by FDG-PET, with net bias such that LVEF measurements in both models of heart disease exceeded by 15% to 20% results obtained by MRI. In our subsequent monitoring study of DCM mice, we found a significant decrease of LVEF in the EPO group, but not in the saline-treated mice. Moreover, LVEF in the EPO and saline mice significantly correlated with histological scores of fibrosis.

conclusionsLVEF estimated by ECG-gated FDG-PET significantly correlated with the reference standard MRI, most notably in healthy mice and mice with DCM. FDG-PET served for longitudinal monitoring of effects of EPO treatment in DCM mice.

Identifiers

PMID22863174
PMCPMC3441325
OpenAlexW2132828152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.